The Claim
In patients with high-risk smoldering myeloma, whole-body MRI is capable of detecting bone marrow infiltration in the absence of focal lesions in a subset of patients, and this detection may influence decisions to initiate early treatment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For some people with an early form of blood cancer called smoldering myeloma, a special full-body scan (MRI) can spot hidden cancer cells in the bone marrow—even when there are no visible tumors—and this might help doctors decide to start treatment sooner.
See the scientific wording
In high-risk smoldering myeloma, whole-body MRI detects bone marrow infiltration without focal lesions in a subset of patients, which may influence early treatment decisions.
What the research says
1 studyThis study found that a special type of MRI scan can spot early signs of cancer in the bone marrow of high-risk patients, even when there are no visible tumors — and this helped doctors decide to start treatment earlier in some cases.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.